BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 22954141)

  • 1. Enantioselective total synthesis of pladienolide B: a potent spliceosome inhibitor.
    Ghosh AK; Anderson DD
    Org Lett; 2012 Sep; 14(18):4730-3. PubMed ID: 22954141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expedient Total Syntheses of Pladienolide-Derived Spliceosome Modulators.
    Rhoades D; Rheingold AL; O'Malley BW; Wang J
    J Am Chem Soc; 2021 Apr; 143(13):4915-4920. PubMed ID: 33755462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enantioselective synthesis of pladienolide B and truncated analogues as new anticancer agents.
    Kumar VP; Chandrasekhar S
    Org Lett; 2013 Jul; 15(14):3610-3. PubMed ID: 23822896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total Synthesis of the Spliceosome Modulator Pladienolide B via Asymmetric Alcohol-Mediated syn- and anti-Diastereoselective Carbonyl Crotylation.
    Yoo M; Krische MJ
    Angew Chem Int Ed Engl; 2021 Jun; 60(25):13923-13928. PubMed ID: 33794050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A synthetic entry to pladienolide B and FD-895.
    Mandel AL; Jones BD; La Clair JJ; Burkart MD
    Bioorg Med Chem Lett; 2007 Sep; 17(18):5159-64. PubMed ID: 17681759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total synthesis of the potent antitumor macrolides pladienolide B and D.
    Kanada RM; Itoh D; Nagai M; Niijima J; Asai N; Mizui Y; Abe S; Kotake Y
    Angew Chem Int Ed Engl; 2007; 46(23):4350-5. PubMed ID: 17437311
    [No Abstract]   [Full Text] [Related]  

  • 7. Total Syntheses of Pladienolide-Derived Spliceosome Modulators.
    Sim J; Jang E; Kim HJ; Jeon H
    Molecules; 2021 Sep; 26(19):. PubMed ID: 34641481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of the macrocyclic core of (-)-pladienolide B.
    Skaanderup PR; Jensen T
    Org Lett; 2008 Jul; 10(13):2821-4. PubMed ID: 18510332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-mRNA splicing-modulatory pharmacophores: the total synthesis of herboxidiene, a pladienolide-herboxidiene hybrid analog and related derivatives.
    Lagisetti C; Yermolina MV; Sharma LK; Palacios G; Prigaro BJ; Webb TR
    ACS Chem Biol; 2014 Mar; 9(3):643-8. PubMed ID: 24377313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor compounds based on a natural product consensus pharmacophore.
    Lagisetti C; Pourpak A; Jiang Q; Cui X; Goronga T; Morris SW; Webb TR
    J Med Chem; 2008 Oct; 51(19):6220-4. PubMed ID: 18788726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the spliceosome in chronic lymphocytic leukemia with the macrolides FD-895 and pladienolide-B.
    Kashyap MK; Kumar D; Villa R; La Clair JJ; Benner C; Sasik R; Jones H; Ghia EM; Rassenti LZ; Kipps TJ; Burkart MD; Castro JE
    Haematologica; 2015 Jul; 100(7):945-54. PubMed ID: 25862704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic studies on aculeximycin: synthesis of C24-C40 segment by Kobayashi aldolization and epoxide rearrangements.
    Kato T; Sato T; Kashiwagi Y; Hosokawa S
    Org Lett; 2015 May; 17(9):2274-7. PubMed ID: 25905567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological validation that SF3b is a target of the antitumor macrolide pladienolide.
    Yokoi A; Kotake Y; Takahashi K; Kadowaki T; Matsumoto Y; Minoshima Y; Sugi NH; Sagane K; Hamaguchi M; Iwata M; Mizui Y
    FEBS J; 2011 Dec; 278(24):4870-80. PubMed ID: 21981285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative total synthesis of dendrodolide-L.
    Musulla S; Bharathi Kumari Y; Madala M; Srinivasa Rao A; Vema VN
    Nat Prod Res; 2020 Nov; 34(21):3089-3093. PubMed ID: 31104527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural Basis of Splicing Modulation by Antitumor Macrolide Compounds.
    Cretu C; Agrawal AA; Cook A; Will CL; Fekkes P; Smith PG; Lührmann R; Larsen N; Buonamici S; Pena V
    Mol Cell; 2018 Apr; 70(2):265-273.e8. PubMed ID: 29656923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Test-firing ammunition for spliceosome inhibition in cancer.
    Dehm SM
    Clin Cancer Res; 2013 Nov; 19(22):6064-6. PubMed ID: 24097858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cryo-EM structure of the SF3b spliceosome complex bound to a splicing modulator reveals a pre-mRNA substrate competitive mechanism of action.
    Finci LI; Zhang X; Huang X; Zhou Q; Tsai J; Teng T; Agrawal A; Chan B; Irwin S; Karr C; Cook A; Zhu P; Reynolds D; Smith PG; Fekkes P; Buonamici S; Larsen NA
    Genes Dev; 2018 Feb; 32(3-4):309-320. PubMed ID: 29491137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereoselective synthesis of amphidinolide T1.
    Yadav JS; Reddy ChS
    Org Lett; 2009 Apr; 11(8):1705-8. PubMed ID: 19323491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Splicing factor SF3b as a target of the antitumor natural product pladienolide.
    Kotake Y; Sagane K; Owa T; Mimori-Kiyosue Y; Shimizu H; Uesugi M; Ishihama Y; Iwata M; Mizui Y
    Nat Chem Biol; 2007 Sep; 3(9):570-5. PubMed ID: 17643112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amphidinolide B: total synthesis, structural investigation, and biological evaluation.
    Lu L; Zhang W; Nam S; Horne DA; Jove R; Carter RG
    J Org Chem; 2013 Mar; 78(6):2213-47. PubMed ID: 23406192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.